465 related articles for article (PubMed ID: 19238094)
61. New insights into the management of hepato-renal syndrome.
Hasper D; Jörres A
Liver Int; 2011 Sep; 31 Suppl 3():27-30. PubMed ID: 21824281
[TBL] [Abstract][Full Text] [Related]
62. Outcomes for hepatorenal syndrome and acute kidney injury in patients undergoing liver transplantation: a single-center experience.
Shusterman B; Mchedishvili G; Rosner MH
Transplant Proc; 2007 Jun; 39(5):1496-500. PubMed ID: 17580171
[TBL] [Abstract][Full Text] [Related]
63. Hepatorenal Acute Kidney Injury and the Importance of Raising Mean Arterial Pressure.
Velez JC; Kadian M; Taburyanskaya M; Bohm NM; Delay TA; Karakala N; Rockey DC; Nietert PJ; Goodwin AJ; Whelan TP
Nephron; 2015; 131(3):191-201. PubMed ID: 26485256
[TBL] [Abstract][Full Text] [Related]
64. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
[TBL] [Abstract][Full Text] [Related]
65. Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes.
Rodriguez E; Henrique Pereira G; Solà E; Elia C; Barreto R; Pose E; Colmenero J; Fernandez J; Navasa M; Arroyo V; Ginès P
Liver Transpl; 2015 Nov; 21(11):1347-54. PubMed ID: 26178066
[TBL] [Abstract][Full Text] [Related]
66. Outcomes of living donor liver transplantation for patients with preoperative type 1 hepatorenal syndrome and acute hepatic decompensation.
Chok KS; Fung JY; Chan SC; Cheung TT; Sharr WW; Chan AC; Fan ST; Lo CM
Liver Transpl; 2012 Jul; 18(7):779-85. PubMed ID: 22290625
[TBL] [Abstract][Full Text] [Related]
67. Terlipressin and gelafundin: safe therapy of hepatorenal syndrome.
Saner F; Kavuk I; Lang H; Biglarnia R; Frühauf NR; Schäfers RF; Malagó M; Broelsch CE
Eur J Med Res; 2004 Feb; 9(2):78-82. PubMed ID: 15090293
[TBL] [Abstract][Full Text] [Related]
68. Hepatorenal syndrome.
Guevara M; Rodés J
Int J Biochem Cell Biol; 2005 Jan; 37(1):22-6. PubMed ID: 15381144
[TBL] [Abstract][Full Text] [Related]
69. Which patients benefit from hemodialysis therapy in hepatorenal syndrome?
Witzke O; Baumann M; Patschan D; Patschan S; Mitchell A; Treichel U; Gerken G; Philipp T; Kribben A
J Gastroenterol Hepatol; 2004 Dec; 19(12):1369-73. PubMed ID: 15610310
[TBL] [Abstract][Full Text] [Related]
70. [Hepatorenal syndrome].
Radziszewski A; Sułowicz W
Przegl Lek; 2006; 63(7):573-8. PubMed ID: 17203812
[TBL] [Abstract][Full Text] [Related]
71. Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT).
Ruiz R; Barri YM; Jennings LW; Chinnakotla S; Goldstein RM; Levy MF; McKenna GJ; Randall HB; Sanchez EQ; Klintmalm GB
Liver Transpl; 2007 Jun; 13(6):838-43. PubMed ID: 17539003
[TBL] [Abstract][Full Text] [Related]
72. Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis.
Rodríguez E; Elia C; Solà E; Barreto R; Graupera I; Andrealli A; Pereira G; Poca M; Sánchez J; Guevara M; Soriano G; Alessandria C; Fernández J; Arroyo V; Ginès P
J Hepatol; 2014 May; 60(5):955-61. PubMed ID: 24447876
[TBL] [Abstract][Full Text] [Related]
73. Therapy insight: Management of hepatorenal syndrome.
Cárdenas A; Ginès P
Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):338-48. PubMed ID: 16741553
[TBL] [Abstract][Full Text] [Related]
74. Treatment of orthostatic hypotension with midodrine and octreotide.
Hoeldtke RD; Horvath GG; Bryner KD; Hobbs GR
J Clin Endocrinol Metab; 1998 Feb; 83(2):339-43. PubMed ID: 9467537
[TBL] [Abstract][Full Text] [Related]
75. Management of hepatorenal syndrome.
McCormick PA; Donnelly C
Pharmacol Ther; 2008 Jul; 119(1):1-6. PubMed ID: 18539334
[TBL] [Abstract][Full Text] [Related]
76. Terlipressin and albumin combination treatment in patients with hepatorenal syndrome type 2.
Nguyen-Tat M; Jäger J; Rey JW; Nagel M; Labenz C; Wörns MA; Galle PR; Marquardt JU
United European Gastroenterol J; 2019 May; 7(4):529-537. PubMed ID: 31065370
[TBL] [Abstract][Full Text] [Related]
77. Immediate recovery of renal function after orthotopic liver transplantation in a patient with hepatorenal syndrome requiring hemodialysis for more than 8 months.
Storm C; Bernhardt WM; Schaeffner E; Neuhaus R; Pascher A; Neuhaus P; Hasper D; Frei U; Kahl A
Transplant Proc; 2007 Mar; 39(2):544-6. PubMed ID: 17362778
[TBL] [Abstract][Full Text] [Related]
78. Hepatorenal syndrome: diagnostic accuracy, clinical features, and outcome in a tertiary care center.
Watt K; Uhanova J; Minuk GY
Am J Gastroenterol; 2002 Aug; 97(8):2046-50. PubMed ID: 12190175
[TBL] [Abstract][Full Text] [Related]
79. Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study.
Guevara M; Terra C; Nazar A; Solà E; Fernández J; Pavesi M; Arroyo V; Ginès P
J Hepatol; 2012 Oct; 57(4):759-65. PubMed ID: 22732511
[TBL] [Abstract][Full Text] [Related]
80. Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: a new exception to MELD score in the allocation system to liver transplantation?
Piano S; Morando F; Fasolato S; Cavallin M; Boscato N; Boccagni P; Zanus G; Cillo U; Gatta A; Angeli P
J Hepatol; 2011 Aug; 55(2):491-6. PubMed ID: 21334405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
